A 64-yr-old asthmatic patient underwent a two-vessel aortocoronary vein grafting. Before surgery, the patient received dmetidine 400 mg and labetalol 650 mg. During the first 60min of bypass, hypotension (40-43 mm Hg) was observed in spite of phenylephrine 14 mg. This initial hypotension was followed, during icwaiming, by a slow increase in arterial pressure to lSOmmHg. On cessation of bypass, bronchospasm was observed and was protracted. It is assumed that labetalol clearance and metabolism were reduced by cimetidine, that labetalol alpha-antagonism was responsible for the vasodilatatkm withstanding the phenylephrine, and that a combination of labetalol beta-antagonism and phenylephrine alpha-agonism initiated the bronchospasm. These observations indicate that, after labetalol therapy, higher doses of vasopressor agents such as phenylephrine may be necessary, but that such therapy may lead to bronchospasm in asthmatic patients.
The patient, a 64-yr-old, 74-kg male, had no known allergy, but had suffered from spastic bronchitis with occasional crises of asthma since 1977. In May 1982, angina was noted for the first time. Arterial hypertension (180/110 mm Hg at rest) was diagnosed at that time and treated with prenylamine, nitrates and diet. Spirometry showed a mild obstructive syndrome with FEVi 92% of the predicted value. In August 1982, a gastric ulcer was diagnosed and cimetidine 400 mg twice daily by mouth commenced. In September 1982, he was admitted to hospital for angina on minimal exertion with no symptoms of congestive heart.failure. After 1 week of therapy with metoprolol 100 mg a day by mouth, shortness of breath with wheezing occurred and the metoprolol was replaced with prenylamine.
Cardiac catheterization revealed normal left ventricular function. The coronary arteriogram identified a 70% obstruction of the left main stem artery and a subtotal obstruction of both the left anterior descending (LAD) and the right coronary (RCA) arteries. The patient was scheduled for a two-vessel aortocoronary vein grafting (LAD and RCA) in November. One week before the scheduled opera- tion he was admitted as an emergency on account of unstable angina and hypertension (200/75 mm Hg). An intra-aortic balloon pump (IABP) was inserted. Nitrates i.v. and labetalol 50 mg as a bolus, followed by an infusion of labetalol 600 mg during the next 15h, were administered. Other haemodynamic data, arterial blood-gas tensions (room air), chest x-ray and haematological investigations, including cardiac enzymes, were normal. The patient was scheduled for surgery the day after admission.
At 7 a.m., the patient was premedicated with morphine 10 mg, atropine 0.5 mg and dmetidine 400 mg i.v. The infusion of labetalol was stopped at 7.30 a.m. At 8 a.m., the patient arrived in the operating theatre under IABP and still receiving nitroglycerine i.v. Arterial pressure was 140/ 80 mm Hg and heart rate 70 beat min-'. He was not wheezing. Anaesthesia was induced with fentanyl 0.25 mg and etomidate 12 mg. Intubation of the trachea was accomplished following suxamethonium 75mg and the topical administration of lignocaine 160 mg. Pancuronium 0.1 mgkg" 1 i.v. was given and the lungs ventilated artificially with 50% nitrous oxide in oxygen. An ultrasonic nebulizer was not used. The peak inspiratory pressure was 18 cm H 2 O. Anaesthesia was maintained with incremental doses of fentanyl, and pancuronium was administered as required. Haemodynamic values remained satisfactory until extracorporeal circulation and hypothermia were initiated.
At 10.45a.m., the aorta was cross-clamped and cardioplegia started. Cardioplegia solution con-sisted of procaine 200 mg, magnesium, sulphate 2.5 g, potassium chloride 14mmollitre' 1 and bicarbonate 7mmollitre~1 in Hartman's solution 1000 ml. In spite of appropriate pump flow and large increments of phenylephrine (total dose 14 mg), the radial artery pressure remained inadequate (between 40-45 mm Hg) during the first 60min of bypass. During the rewarming phase, the arterial pressure began to increase steadily up to 150 mm Hg in 30 min. After one internal direct cardioversion, the patient came off bypass. A peak inspiretory pressure of 50 cm H 2 O was noted with no movement of the chest. Arterial pressure and heart rate decreased and the patient was placed back on partial bypass. The ventilator was carefully checked and was found to be working satisfactorily. Suction via the tracheal tube and a bolus of hydrocortisone lOOmg did not improve the situation. Fibreoptic bronchoscopy revealed a small amount of mucous plugging and widespread oedema, and a presumptive diagnosis of asthma was made. Aminophylline 6mgkg -1 i.v. and hydrocortisone 250 mg i.v. did not alleviate the bronchospasm. An infusion of adrenaline 2 -5 fig min-1 was started and the bronchospasm subsided in 30 min. During that time, an arterial pressure of 120/70 mm Hg and a heart rate of 95 beat min" 1 in sinus rhythm were recorded. A second attempt to terminate bypass was successful. The procedure was terminated at 3.15p.m. with no other major respiratory or cardiovascular changes.
In the Acute Care Unit, the recovery of the patient was uneventful. The infusion of adrenaline was discontinued 1 h after admission. The tracheal tube was removed the following morning and the patient was gradually weaned off the IABP in the afternoon. He was discharged from the hospital 3 weeks later with no further episode of bronchospasm. Six months after the procedure, the patient was in a satisfactory condition.
DISCUSSION
To our knowledge, only three cases of bronchospasm during cardiopuknonary bypass have been reported (Vanetti et al., 1973; Shiroka, Rah and Keenan, 1982) . On each occasion, the aetiology was not known precisely and the presumptive diagnosis was made when close examination of the chest, checking of equipment, suction of the tube and fibreoptic bronchoscopy had ruled out all other possible mechanical causes of the increase in inspiratory pressures. According to Aviado( 1975) and Hirshman (1983) , numerous factors modify airway reactivity during anaesthesia. Some may be implicated in the present case: light level of anaesthesia; decreased temperature in the bronchi; mechanical irritation of the respiratory tract (endotracheal tube and surgical manipulations); histaminp release from blood products, anaesthetic agents, priming or cardioplegic solutions, or pump oxygenator; autonomic imbalance. Substantial evidence supports the hypothesis that autonomic imbalance resulting from the interactions of labetalol, cimetidine and phenylephrine was the main determinant in the initiation of the bronchospasm observed in this patient.
Labetalol is a competitive alpha-and betaadrenoreceptor antagonist, some four to five times more potent as an antagonist at beta-receptors than at alpha-receptors (Boakes, Knight and Prichard, 1971; Farmer et al., 1972; Mehta and Conn, 1977) . Labetalol was administered because, compared with beta-receptor blockade alone, it offered significant haemodynamic advantages in the acute treatment of hypertension (Koch, 1977) . In contrast to Skinner, Gaddie and Palmer (1975) , Larsson (1982) reported that labetalol does produce bronchoconstriction. Nevertheless, our patient tolerated the infusion of labetalol well. His arterial pressure was returned to normal and he did not complain of the shortness of breath evident during therapy with metoprolol. In regard to the bronchospasm, we believe that an additional role was played by cimetidine and phenylephrine. Cimetidine, a histamincz-receptor antagonist, decreases liver blood flow and inhibits hepatic drug-metabolizing enzymes, thereby decreasing the systemic clearance and the extraction ratio of drugs like propranolol and labetalol (George, 1979; Feely, Wilkinson and Wood, 1981) . Therefore, it is likely that the terminal half-life of labetalol, which is 3.5-4.5h after injection i.v. (Smith and Tucker, 1981) , had been increased significantly by cimetidine. In addition, alpha-receptor activation may cause bronchoconstriction when a pre-existing beta-receptor blockade is present. Leff and Munoz (1981) demonstrated in dogs that phenylephrine caused dose-related tracheal contraction, and that pre-treatment with propranolol increased tracheal contraction. Thus, we feel that the phenylephrine-induced alpha-receptor activation and the labetalol-induced beta-receptor inhibition were the key factors which led to the bronchospasm.
It is possible that the administration i.v. of selective beta 2 -agonists, such as terbutaline, would have been more effective than adrenaline, although the possible vasodilating effect of beta 2 -stimulation must be considered (Wunderlich et al, 1980) . Such therapy would merit further study after labetalol administration.
Continued hypotension occurring in the presence of high doses of phenylephrine during bypass has not been reported previously. A rational explanation of the resistance to a selective alpha-receptor agonist, such as phenylephrine, is a pre-existing alphareceptor blockade. Alpha-blocking activity with increasing doses of labetalol i. v., as judged by progressive parallel inhibition of the vasopressor responses to injection i.v. of phenylephrine, has been demonstrated in human volunteers (Boakes, Knight and Prichard, 1971) and anaesthetized dogs (Kennedy and Levy, 1975; Sybertz et al., 1981) . Therefore, the alpha-blocking effect of labetalol was gradually overcome by the intense alpha-stimulating effect of phenylephrine, and may explain the low arterial pressure during the first 60 min of bypass, followed by a steady increase up to ISOmmHg during the 30 min of re warming. Furthermore, in anaesthetized dogs and cats, labetalol (in doses greater than 1 mg kg" 1 ) is a relatively ineffective antagonist of vasopressor responses to noradrenaline. This paradoxical effect may occur secondary to a blockade of adrenergic re-uptake (Farmer et al., 1972; Kennedy and Levy, 1975) . Therefore, after labetalol therapy, pressor responses to noradrenaline may be less predictable than those to phenylephrine. Further investigations of these differences would be valuable.
In conclusion, should labetalol be discontinued before surgery? No generalization can be made from the present case. However, higher doses of vasopressor agents such as phenylephrine may be necessary during surgery, although such vasopressor therapy may lead to bronchospasm in asthmatic patients. 
